P285: Comparison of two nucleic acid amplification assays, the probetec et assay and xpert mtb/rif assay, for detection of mycobacterium tuberculosis in respiratory specimens by S Aljohani & M Alshomrani
POSTER PRESENTATION Open Access
P285: Comparison of two nucleic acid
amplification assays, the probetec et assay and
xpert mtb/rif assay, for detection of
mycobacterium tuberculosis in respiratory
specimens
S Aljohani1*, M Alshomrani2
From 2nd International Conference on Prevention and Infection Control (ICPIC 2013)
Geneva, Switzerland. 25-28 June 2013
Introduction
Early diagnosis and management of TB is critical to
reduce TB transmission in communities and health care
facilities. In developing countries, TB diagnosis is largely
based on smear microscopy of sputum samples.
Nucleic acid amplification tests (NAATs) have greatly
facilitated TB testing by lowering the turnaround time
to a day or less from two or more weeks for a culture
result.
Objectives
Our aim is to evaluate the diagnostic performance of the
Xpert MTB/RIF and BD ProbTec Strand Displacement
Amplification assays on smear-positive and smear-negative
patient specimens submitted to King Abduaziz Medical
City laboratory, in Riyadh, Saudi Arabia from July to Mid
Nov 2012, the study still ongoing to collect more data.
Methods
A total of 35 consecutive specimens were subjected to
the two molecular assays, and their performance charac-
teristics were assessed relative to the routine diagnostic
standard. Both assays showed similar diagnostic perfor-
mance characteristics.
Clinical specimens were divided into two equal portions,
one for the Xpert MTB/RIF test and the other one for
ProbTec ET assay. NAAs were applied in parallel in a
blind manner by one laboratory technician, and the results
from the two assays were compared by a second person.
The Xpert MTB/RIF method BD ProbeTec performed
as per manufacturer instructions.
Results
Of the 35 samples tested, there were seven samples that
are positive by both PCR as well as by culture. Eight
samples were positive by ProbTec alone and one sample
positive by Xpert alone. The sensitivities of the BD
ProbTec and Xpert MTB/RIF assays for the detection of
culture-positive M. tuberculosis were 87.5%, while the
specificities of both assays were 70%> 96.3% , respec-
tively. Both assays were able to diagnose the presence of
M. tuberculosis in 57 to 58% of smear-negative cases,
suggesting that the performance characteristics were
dependent on bacillary load.
Conclusion
Performance of both assays relatively good, Performance
of GeneXpert superior to BD probTec, inconjuction to
ease of use and availability of Rifampin susceptibility
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